Aster DM Quality CareNSE:ASTERDM +0.22%77 5-Year Yield-on-Cost % is 0.49 as of Jul. 12, 2026, which is 34% below its 10-year median of 0.74. GuruFocus rates NSE:ASTERDM with a GF Score™ of 77/100 and a GF Value™ of ₹675.83 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Aster DM Quality Care ranks worse than 89.32% on this metric.
Aster DM Quality Care's yield on cost for the quarter that ended in Mar. 2026 was 0.49.
The historical rank and industry rank for Aster DM Quality Care's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:ASTERDM'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.38 Med: 0.74 Max: 1.24
Current: 0.49
During the past 12 years, Aster DM Quality Care's highest Yield on Cost was 1.24. The lowest was 0.38. And the median was 0.74.
NSE:ASTERDM's 5-Year Yield-on-Cost % is ranked worse than 89.32% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.92
vs NSE:ASTERDM: 0.49
Aster DM Quality Care (NSE:ASTERDM) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Aster DM Quality Care 5-Year Yield-on-Cost % Related Terms
NSE:ASTERDM vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's 5-Year Yield-on-Cost % falls into.
Aster DM Quality Care 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Aster DM Quality Care (NSE:ASTERDM) has a 5-Year Yield-on-Cost % of 0.49 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Aster DM Quality Care and its competitors. This is 34% below median its historical median of 0.74. Over the past decade, Aster DM Quality Care's 5-Year Yield-on-Cost % has ranged from 0.38 to 1.24. According to the industry distribution chart, Aster DM Quality Care ranks #251 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 89.3%.
Is Aster DM Quality Care's 5-Year Yield-on-Cost % too high?
Aster DM Quality Care's current 5-Year Yield-on-Cost % of 0.49 is 34% below median its 10-year median of 0.74. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 1.24. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.92. Aster DM Quality Care's value of 0.49 is 83.2% below this industry median. Based on the distribution chart, Aster DM Quality Care ranks #251 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aster DM Quality Care has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #251 out of 281 companies for 5-Year Yield-on-Cost %. This places Aster DM Quality Care in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. Aster DM Quality Care's value of 0.49 is 83.2% below this benchmark. Historically, Aster DM Quality Care's own 5-Year Yield-on-Cost % has ranged from 0.38 to 1.24 over the past decade. While the company's 10-year median is 0.74 vs. the industry median of 2.92, Aster DM Quality Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current 5-Year Yield-on-Cost % of 0.49 is 83.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Aster DM Quality Care and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current 5-Year Yield-on-Cost % is 0.49, which is 34% below median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹675.83, compared to a current price of ₹808.90 — trading 19.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.49, which is 34% below median its 10-year median of 0.74 and 83.2% below the Healthcare Providers & Services industry median of 2.92. Aster DM Quality Care's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current 5-Year Yield-on-Cost % is 0.49 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹808.90 is trading 19.7% above its estimated GF Value™ of ₹675.83.
GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.
Key valuation signals for NSE:ASTERDM:
5-Year Yield-on-Cost %: 0.49 (34% below median its 10-year median of 0.74)
GF Value™: ₹675.83 vs. price of ₹808.90 (19.7% above fair value)
Industry Position: 83.2% below the Healthcare Providers & Services median (#251 of 281)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
77GF Score
Get the complete analysis for NSE:ASTERDM
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 